Opportunity Information: Apply for PAR 23 194
The Substance Use/Substance Use Disorder Dissertation Research Award (R36, Clinical Trials Not Allowed) is a National Institutes of Health funding opportunity from the National Institute on Drug Abuse (NIDA) designed to help doctoral candidates finish their dissertation research in areas related to substance use and substance use disorders. The core purpose is to provide up to two years of support so advanced doctoral students from a wide range of academic disciplines can complete a clearly defined dissertation project that strengthens the evidence base around substance use, addiction, prevention, treatment, recovery, and related public health and behavioral outcomes. By focusing on dissertation-stage researchers, the program is meant to act as an early on-ramp into the substance use and addiction research field, helping build a strong pipeline of new investigators.
Projects supported under this award are expected to align closely with NIDA priorities, either through NIDA's published funding priorities or through the institute's strategic planning framework. In practice, that means the dissertation research should fit within NIDA's mission-driven areas, such as understanding the causes and consequences of substance use, improving prevention and treatment approaches, addressing overdose and drug-related harms, studying services and systems that deliver care, and examining how substance use intersects with mental health, social factors, and health disparities. The award is specifically labeled "Clinical Trials Not Allowed," which means applicants must propose research that does not meet NIH's definition of a clinical trial; the work can still be rigorous and applied, but it cannot involve prospectively assigning human participants to an intervention to evaluate health-related outcomes.
A major emphasis of this opportunity is workforce development, including strengthening diversity in the substance use research workforce. Applications are particularly encouraged from doctoral candidates who would contribute to broadening representation in research, consistent with NIH's stated interest in diversity (NOT-OD-20-031). The intent is not only to fund individual projects, but also to expand who is conducting substance use research, bringing in perspectives and expertise from different backgrounds, disciplines, and communities, and ultimately improving the relevance and reach of research findings.
Eligibility is broad on the organizational side, reflecting NIH's typical range of applicant institutions. Eligible applicants include many types of U.S.-based organizations and governments, such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses) and small businesses, as well as state, county, city/township, and special district governments, independent school districts, and public housing authorities/Indian housing authorities. Federally recognized Native American tribal governments are eligible, as are tribal organizations that are not federally recognized. The announcement also highlights additional categories of eligible applicant organizations that NIH particularly calls out, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
At the same time, the opportunity places clear limits on foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as NIH defines them in the NIH Grants Policy Statement, are allowed, meaning a U.S.-based applicant may be able to include certain well-justified foreign elements in the research (for example, collaborations or specific research activities abroad) if they meet NIH policy requirements.
Administrative details from the source listing identify this as a discretionary grant program (funding instrument type: Grant) within the Education and Health activity categories and associated with CFDA number 93.279. The funding opportunity number is PAR-23-194, created June 15, 2023, with an original closing date of September 7, 2026. The listing does not specify an award ceiling or the expected number of awards in the provided fields, so applicants generally need to consult the full FOA text and NIH budget guidance for the R36 mechanism to understand allowable costs, budget structure, and any institute-specific expectations.Apply for PAR 23 194
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2023-06-15.
- Applicants must submit their applications by 2026-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36)
Previous opportunity: Book Translation Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 194
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 194) also looked into and applied for these:
| Funding Opportunity |
|---|
| The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA HL 24 011 Funding Number: RFA HL 24 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional) Apply for RFA HL 24 010 Funding Number: RFA HL 24 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional) Apply for RFA CA 23 027 Funding Number: RFA CA 23 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional) Apply for RFA CA 23 026 Funding Number: RFA CA 23 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AT 24 002 Funding Number: RFA AT 24 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,300,000 |
| ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed) Apply for RFA OD 23 018 Funding Number: RFA OD 23 018 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Apply for PA 23 231 Funding Number: PA 23 231 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) Apply for RFA CA 23 037 Funding Number: RFA CA 23 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) Apply for RFA CA 23 036 Funding Number: RFA CA 23 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $325,000 |
| NIH-DoD-VA Pain Management Collaboratory ? Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 24 004 Funding Number: RFA AT 24 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed) Apply for RFA DA 25 014 Funding Number: RFA DA 25 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Apply for PAR 23 246 Funding Number: PAR 23 246 Agency: National Institutes of Health Category: Education, Health Funding Amount: $475,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional) Apply for RFA DA 25 020 Funding Number: RFA DA 25 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) Apply for RFA DA 25 019 Funding Number: RFA DA 25 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required) Apply for RFA DA 25 002 Funding Number: RFA DA 25 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $225,000 |
| Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional) Apply for RFA DA 25 001 Funding Number: RFA DA 25 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 23 254 Funding Number: PAR 23 254 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 23 255 Funding Number: PAR 23 255 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 23 245 Funding Number: PAR 23 245 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) Apply for PAR 23 259 Funding Number: PAR 23 259 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 194", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.